Members |
targetComponentId |
Beclomethasone dipropionate+salbutamol |
Product containing beclometasone and salbutamol (medicinal product) |
beclometasondipropionat 200 µg + salbutamol 400 µg inhalationspulver, kapsel |
Product containing only beclometasone and salbutamol (medicinal product) |
Bedpan |
Bedpan |
Beetle |
Order Coleoptera (organism) |
Behavior disorder of childhood and adolescence |
Behavior problem of childhood and adolescence (finding) |
Bell-Beuttners operation for subtotal abdominal hysterektomi |
Subtotal abdominal hysterectomy |
belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
Belladonna alkaloids + ergotamine tartrate + phenobarbital 0.2mg/0.6mg/40mg prolonged-release oral tablet |
Product containing only belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form) |
bemiparinnatrium 22.500 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml |
Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug) |
bemiparinnatrium 40.000 IE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,4 ml |
Bemiparin sodium 40000 unit/mL solution for injection |
Bendamustine 100mg powder for injection solution 20ml vial |
Bendamustine hydrochloride 100 mg powder for solution for injection vial |
Benefits - other, specified |
Benefits and pensions |
Benefits - other, specified |
Benefits and pensions |
benignt adenomatøst neoplasme iht. kategori |
Benign adenomatous neoplasm (morphologic abnormality) |
Benign carcinoid neoplasm of bronchus |
Carcinoid tumour of bronchus |
Benign carcinoid of large intestine |
Well-differentiated neuroendocrine tumor of large intestine |
Benign carcinoid of lung |
Carcinoid tumour of lung |
Benign carcinoid tumor |
Well-differentiated neuroendocrine tumour |
Benign carcinoid tumor |
Well-differentiated neuroendocrine tumor (morphologic abnormality) |
Benign carcinoid tumor of gastrointestinal tract |
Well-differentiated neuroendocrine tumor of gastrointestinal tract |
Benign carcinoid tumor of left kidney |
Well-differentiated neuroendocrine tumor of left kidney (disorder) |
Benign carcinoid tumor of liver |
Well-differentiated neuroendocrine tumor of liver |
Benign carcinoid tumor of pancreas |
Neuroendocrine tumor of pancreas (disorder) |
Benign carcinoid tumor of right kidney |
Well-differentiated neuroendocrine tumor of right kidney (disorder) |
Benign childhood epilepsy with centrotemporal spikes, non-refractory |
A common type of self-limited focal epilepsy syndrome, which begins typically between four and ten years (peak is seven years; range three to twelve years). Seizures are focal, infrequent (most children have fewer than ten in lifetime), brief (typically less than two to three minutes) and occur mostly in sleep (eighty to ninety percent of children). Individuals may have frequent seizures over a few days or weeks and then several months before subsequent seizure. Focal seizures with characteristic frontoparietal opercular features and/or nocturnal bilateral tonic-clonic seizures are mandatory for diagnosis. Characteristic semiology includes somatosensory symptoms (unilateral numbness or paresthesia of the tongue, lips, gums and inner cheek), orofacial motor signs (unilateral tonic or clonic contractions), speech arrest (dysarthria or anarthria) with preserved understanding, and sialorrhea. Seizures may evolve rapidly to tonic-clonic activity of the ipsilateral upper limb, to an ipsilateral hemiclonic seizure, or to a focal to bilateral tonic-clonic seizure. Todd paresis may occur postictally. Seizures occurring during sleep are seen within one hour of falling asleep or one to two hours prior to awakening. Development and cognition are typically normal. Neurological examination is normal. The electroencephalogram (EEG) background activity is normal. EEG must show centrotemporal biphasic epileptiform discharges which are characteristically high-amplitude complexes (less than 200 microvolts, peak to trough) that activate in drowsiness and sleep. MRI is normal or has nonspecific findings. |
Benign cyst of breast |
Cyst of breast (disorder) |
benignt epitelialt neoplasme iht. kategori |
Benign epithelial neoplasm |
Benign essentiel hypertension, der komplicerer graviditet, fødsel og puerperium, med postnatal komplikation |
Benign essential hypertension complicating pregnancy, childbirth and the puerperium |
Benign familiær hæmaturi |
Thin basement membrane disease |
benignt fibrohistiocytisk neoplasme iht. kategori |
Benign fibrohistiocytic neoplasm |
godartet fibromatøst neoplasme iht. kategori |
Benign fibromatous neoplasm |
Benign frontal epilepsi i barndommen |
A type of focal epilepsy where all the seizures originate within the frontal lobe. |
Benign insulinoma |
Malignant insulinoma |
benignt leiomyomatøst neoplasme iht. kategori |
Leiomyoma |
Benign mammary dysplasia NOS |
Benign mammary dysplasia |
Benign mammary dysplasia NOS |
Benign mammary dysplasia |
metastaserende benignt leiomyom i uterus |
Metastasizing leiomyoma of uterus (disorder) |
Benign neonatal seizures |
A type of self-limited focal epilepsy with onset typically between day two and seven of life. Seizures are focal tonic at onset, affecting the head, face, and limbs. Focal clonic or tonic seizures may evolve to bilateral tonic or clonic seizures. Onset may alternate between hemispheres. Autonomic features (apnea and cyanosis) are present in one third of seizures and may be the predominant manifestation. Seizure semiology may progress in a sequential pattern with tonic, clonic, myoclonic and autonomic features following each other without a single predominant feature. Clusters of seizures may occur over hours or days with the neonate behaving normally between events. Developmental progress is usually normal. The electroencephalogram (EEG) background is normal or has minor nonspecific abnormalities. Focal interictal epileptiform abnormalities can be seen in the central, centrotemporal or frontotemporal regions. MRI is normal or has nonspecific findings. Pathogenic variants are seen in KCNQ2, KCNQ3 and SCN2A. |
Benign neoplasm NOS |
Benign neoplastic disease |
Benign neoplasm NOS |
Benign neoplastic disease |
benignt neoplasme i areola mammahos kvinde |
Benign neoplasm of areola |
benignt neoplasme i areola mammae hos mand |
Benign neoplasm of areola |
benignt neoplasme i processus axillaris i mamma hos kvinde |
Benign neoplasm of axillary tail of breast (disorder) |
Benign neoplasm of bone and articular cartilage |
Benign neoplasm of bone |
benignt neoplasme i central del af mamma hos kvinde |
Benign neoplasm of central portion of breast |
Benignt neoplasme i bindevæv og bløddele i peritoneum |
Benign neoplasm of the peritoneum |
benignt neoplasme i ektopisk mammavæv hos kvinde |
Benign neoplasm of ectopic site of breast (disorder) |
Benignt neoplasme i mandligt ektopisk mammavæv |
Benign neoplasm of ectopic site of breast (disorder) |
Benign neoplasm of female breast |
Benign neoplasm of breast |
benignt neoplasme i bryst hos kvinde |
Benign neoplasm of breast |
benign tumor med dårligt defineret lokalisation |
Benign neoplastic disease |
Benign neoplasm of left female breast |
Benign neoplasm of left breast (disorder) |
Benign neoplasm of leg |
Benign neoplasm of bone of lower limb |
benignt neoplasme i nedre mediale kvadrant af mamma hos kvinde |
Benign neoplasm of lower inner quadrant of breast (disorder) |
benignt neoplasme i nedre laterale kvadrant af mamma hos kvinde |
Benign neoplasm of lower outer quadrant of breast (disorder) |
benignt neoplasme i mamma hos mand |
Benign neoplasm of breast |
Benign neoplasm of male breast |
Benign neoplasm of breast |
benignt neoplasme i brystvorte hos kvinde |
Benign neoplasm of nipple (disorder) |
benignt neoplasme i brystvorte hos mand |
Benign neoplasm of nipple (disorder) |
Benign neoplasm of oral cavity NOS |
Benign neoplasm of oral cavity (disorder) |
Benign neoplasm of oral cavity NOS |
Benign neoplasm of oral cavity (disorder) |
Benignt neoplasme i andre specificerede lokalisationer i uterus |
Benign neoplasm of uterus |
Benign neoplasm of right female breast |
Benign neoplasm of right breast (disorder) |
Benign neoplasm of skin (& various types) |
Benign neoplasm of skin |
benignt neoplasme i øvre mediale kvadrant af mamma hos kvinde |
Benign neoplasm of upper inner quadrant of breast |
benignt neoplasme i øvre laterale kvadrant af mamma hos kvinde |
Benign neoplasm of upper outer quadrant of breast (disorder) |
Benign neoplastic process |
Neoplasm, benign |
benign nerveskedetumor iht. kategori |
Benign nerve sheath tumor |
benignt neuroendokrint neoplasme iht. kategori |
Benign neuroendocrine neoplasm |
Benign neuroendocrine neoplasm of ascending colon |
Neuroendocrine neoplasm of ascending colon |
Benign neuroendocrine neoplasm of ileum |
Neuroendocrine neoplasm of ileum (disorder) |
Benign neuroendocrine neoplasm of jejunum |
Neuroendocrine neoplasm of jejunum (disorder) |
Benign neuroendocrine neoplasm of large intestine |
Neuroendocrine neoplasm of large intestine (disorder) |
Benign neuroendocrine neoplasm of pancreas |
Neuroendocrine neoplasm of pancreas (disorder) |
Benign neuroendocrine neoplasm of sigmoid colon |
Neuroendocrine neoplasm of sigmoid colon |
Benign neuroendocrine neoplasm of transverse colon |
Neuroendocrine neoplasm of transverse colon (disorder) |
Benign paroksysmatisk positionel vertigo nystagmus |
Nystagmus due to benign paroxysmal positional vertigo |
Benign postural proteinuria |
Orthostatic proteinuria |
Benign psykomotorisk epilepsi i barndommen |
A group of epilepsies characterized by age-dependent occurrence of drug responsive focal seizures in otherwise normal children. Seizures are focal motor or sensory with or without impaired awareness and may evolve to bilateral tonic-clonic seizures. Remission usually occurs by puberty. Development and cognition are typically normal. Neurological examination is normal. No significant structural lesions of the brain are present, and presumed genetic factors have an important role. The electroencephalogram (EEG) background activity is normal. Seizure semiology and EEG features are specific for each of the syndromes included in this group. |
behandling med Bennettrespirator |
Respiratory therapy |
benoxinathydrochlorid 0,2 % øjendråber |
Oxybuprocaine only product |
benoxinathydrochlorid 0,4 % øjendråber |
Oxybuprocaine only product |
benoxinathydrochlorid + fluoresceinnatrium 0,3 %/0,125 % øjendråber |
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
benoxinathydrochlorid + fluoresceinnatrium 0,4 %/0,25 % opløsning til oftalmisk anvendelse |
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form) |
Benton visual behavior test |
Benton visual retention test (assessment scale) |
benzalkoniumchlorid (i vand) |
Benzalkonium chloride |
allergi over for benzathinpenicillin |
Allergy to benzylpenicillin |
Benzhexol 2mg/5mL conventional release oral solution |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
benzhexol 2 mg/5 ml sukkerfri oral opløsning |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
antipsykotisk benzisoxazolderivatmiddel |
Benzisoxazole derivative |
Benzoate 1,2-dioxygenase |
Benzoate 1,2-dioxygenase (substance) |
benzocain 2% wt/wt + trimethobenzamidhydrochlorid 100 mg suppositorier |
Benzocaine and trimethobenzamide only product in rectal dose form |
Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories |
Benzocaine and trimethobenzamide only product in rectal dose form |
benzocain 20 % øredråber |
Product containing precisely benzocaine 200 milligram/1 milliliter conventional release ear solution (clinical drug) |
allergi over for benzodiazepinsedativum |
Allergy to benzodiazepine |
allergi over for benzoesyre |
Non-allergic hypersensitivity to benzoic acid |
Benzoyl peroxide |
Benzoyl peroxide (substance) |
Benzoyl peroxide + clindamycin phosphate |
Product containing benzoyl peroxide and clindamycin (medicinal product) |
benzoylperoxid 10 % wt/wt + svovl 5 % wt/wt |
Product containing benzoyl peroxide and sulfur (medicinal product) |
benzoylperoxid + svovl 5 % wt/wt/2 % wt/wt |
Product containing benzoyl peroxide and sulfur (medicinal product) |
benzoylperoxid 10 % |
Product containing benzoyl peroxide (medicinal product) |